Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Zora Baretta"'
Autor:
Giulia Tasca, Maria Vittoria Dieci, Zora Baretta, Giovanni Faggioni, Marco Montagna, Maria Ornella Nicoletto, Fedro Alessandro Peccatori, Valentina Guarneri, Nicoletta Colombo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
PurposeWe aimed to evaluate the clinico-pathological characteristics and survival outcomes of patients with synchronous or metachronous breast cancer (BC) and ovarian cancer (OC).Materials and MethodsPatients with synchronous or metachronous BC and O
Externí odkaz:
https://doaj.org/article/5b6bf68058b4418aa1e756b420136b35
Autor:
Giulia Pasello, Stefania Gori, Petros Giovanis, Francesco Rosetti, Fable Zustovich, Andrea Bonetti, Laura Bonanno, Adolfo Favaretto, Carlo Gatti, Antonio Santo, Valentina Guarneri, Zora Baretta, Giovanni Palazzolo, Cristina Oliani, Jessica Menis, Roberta Redelotti, Silvia Toso, Donatella Da Corte, Giovanni Vicario, Pierfranco Conte, Alberto Bortolami, Daniele Bernardi, Stefano Frega, Francesco Oniga, Lorenzo Calvetti, Marco Basso
Introduction Gefitinib, erlotinib, and afatinib represent the approved first-line options for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Because pivotal trials frequently lack external validity, real-world data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c624404b366ec4e1366ccb94e689159
https://europepmc.org/articles/PMC6656504/
https://europepmc.org/articles/PMC6656504/
Autor:
Antonelli, M, Zora, Baretta, Bianco, C, Bianco, R, Bria, E, Cancello, G, Ciardiello, F, Cingarlini, S, Condello, C, Damiano, V, Nullm, nullDe Laurentiis, Nullg, nullDella Vittoria Scarpati, Dieci, Mv, Forestieri, V, Nullg, nullDi Lorenzo, Nullm, nullDi Maio, Guarneri, V, Massari, F, Melisi, D, Morabito, A, Palmieri, G, Pensabene, M, Pepe, S, Perrone, F, Piccirillo, Mc, ARPINO, GRAZIA, CARLOMAGNO, Chiara, BIANCO, ANGELO RAFFAELE, CONTEGIACOMO, ALMA, LAURIA, ROSSELLA, MARINELLI, ALFREDO, MATANO, ELIDE, PERSICO, GIOVANNI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5eb5d01d6a50d58cf2b93759824e3c55
http://hdl.handle.net/11588/687945
http://hdl.handle.net/11588/687945
Autor:
Ivan Solà, Simone Mocellin, Sara Hallum, Marta Martin-Richard, Xavier Bonfill Cosp, Marta Roqué i Figuls, Zora Baretta
Publikováno v:
The Cochrane Library
Background The therapeutic management of people with metastatic colorectal cancer (CRC) who did not respond to first-line treatment represents a formidable challenge. Objectives To determine the efficacy and toxicity of second-line systemic therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137fad1f5d7e536e08e922599c72e75f
http://hdl.handle.net/11577/3234691
http://hdl.handle.net/11577/3234691
Publikováno v:
Personalized Management of Breast Cancer. :100-118
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0d13a172869d5787f16615a8b3918d4
https://doi.org/10.2217/ebo.12.490
https://doi.org/10.2217/ebo.12.490
Autor:
Laura Evangelista, Lorenzo Vinante, Giorgio Saladini, Fernando Bozza, Cristina Ghiotto, Anna Rita Cervino, Michele Gregianin, Zora Baretta
Publikováno v:
Annals of Nuclear Medicine. 25:469-477
A single value of tumor marker elevation is not used for the diagnosis of breast cancer (BC) relapse, whereas the serial measurements which confirm a persistent Ca15.3 increase can represent an early signal of tumor relapse, even if described in asym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6b5f7cfa5e7eeb6bdc52c0043037aa
https://doi.org/10.1007/s12149-011-0488-9
https://doi.org/10.1007/s12149-011-0488-9
Publikováno v:
The Outpatient Breast Clinic ISBN: 9783319159065
• Theoretically if the tumour has not yet disseminated metastases to tissues that are biologically vital, it is curable with local therapy only. • Approximately half of women with operable breast BC who do not receive any systemic therapy will di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d3032c4fb5920e1fca048f0fca13226
https://doi.org/10.1007/978-3-319-15907-2_18
https://doi.org/10.1007/978-3-319-15907-2_18
Publikováno v:
Clinical colorectal cancer. 12(4)
Oxaliplatin-based chemotherapy represents a standard treatment of patients with metastatic colon cancer. Common adverse events of these regimens include sensory neuropathy, myelosuppression, mucositis, and nausea. Chemotherapy-induced thrombotic thro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d665322cb3207338dde9ebbad664e3
https://pubmed.ncbi.nlm.nih.gov/24188688
https://pubmed.ncbi.nlm.nih.gov/24188688
Resistance to trastuzumab, either primary/de novo resistance or acquired/treatment-induced resistance, is a major clinical concern facing breast oncologists today.1 Here, we describe two cases of human epidermal growth factor receptor 2 (HER2)-positi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da1a0d2e26c4be0b65f4b8dbfb5a73d
https://europepmc.org/articles/PMC4816219/
https://europepmc.org/articles/PMC4816219/
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
Background: The contribution of BRCA germline mutational status to breast cancer patients’ prognosis is unclear. We aimed to systematically review and perform meta-analysis of the available
Background: The contribution of BRCA germline mutational status to breast cancer patients’ prognosis is unclear. We aimed to systematically review and perform meta-analysis of the available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f47f5f6941233716fa25decb07c3f94
https://doi.org/10.1097/md.0000000000004975
https://doi.org/10.1097/md.0000000000004975